Fulgent Genetics (FLGT) Short Interest Ratio & Short Volume $21.38 -0.19 (-0.88%) Closing price 04:00 PM EasternExtended Trading$21.36 -0.02 (-0.09%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Fulgent Genetics Short Interest DataFulgent Genetics (FLGT) has a short interest of 2.09 million shares, representing 10.60% of the float (the number of shares available for trading by the public). This marks a 12.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.0, indicating that it would take 7.0 days of the average trading volume of 356,558 shares to cover all short positions.Current Short Interest2,090,000 sharesPrevious Short Interest1,860,000 sharesChange Vs. Previous Month+12.37%Dollar Volume Sold Short$35.91 millionShort Interest Ratio7.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares30,610,000 sharesFloat Size19,720,000 sharesShort Percent of Float10.60%Today's Trading Volume122,673 sharesAverage Trading Volume356,558 sharesToday's Volume Vs. Average34% Short Selling Fulgent Genetics? Sign up to receive the latest short interest report for Fulgent Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFLGT Short Interest Over TimeFLGT Days to Cover Over TimeFLGT Percentage of Float Shorted Over Time Fulgent Genetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,090,000 shares $35.91 million +12.4%10.6%7 $17.18 7/15/20251,860,000 shares $33.61 million -3.6%9.5%6.3 $18.07 6/30/20251,930,000 shares $38.37 million +17.0%9.8%6.2 $19.88 6/15/20251,650,000 shares $34.14 million +2.5%8.4%4.8 $20.69 5/31/20251,610,000 shares $33.18 million -9.0%8.2%3.5 $20.61 5/15/20251,770,000 shares $35.47 million +2.3%9.0%3.6 $20.04 4/30/20251,730,000 shares $30.02 million -1.7%8.8%3.6 $17.35 4/15/20251,760,000 shares $33.58 million +15.8%8.9%4 $19.08 3/31/20251,520,000 shares $25.69 million -7.9%7.7%3.5 $16.90 3/15/20251,650,000 shares $28.45 million +19.6%8.3%4 $17.24 Get the Latest News and Ratings for FLGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,380,000 shares $21.32 million +6.2%7.0%4.5 $15.45 2/15/20251,300,000 shares $21.97 million +23.8%6.5%5.1 $16.90 1/31/20251,050,000 shares $17.47 million -1.9%5.2%3.9 $16.64 1/15/20251,070,000 shares $18.09 million +10.2%5.3%4.2 $16.91 12/31/2024970,600 shares $17.93 million +18.2%4.9%4.1 $18.47 12/15/2024821,300 shares $16.08 million +9.7%4.1%3.7 $19.58 11/30/2024748,900 shares $13.70 million +29.3%3.8%3.7 $18.30 11/15/2024579,100 shares $10.02 million -10.3%2.9%3.2 $17.31 10/31/2024645,600 shares $13.85 million -4.5%3.3%4.3 $21.45 10/15/2024676,100 shares $13.70 million +5.6%3.4%4.6 $20.26 9/30/2024640,100 shares $13.91 million -11.5%3.2%3.8 $21.73 9/15/2024723,200 shares $16.16 million -1.3%3.7%4.1 $22.35 8/31/2024732,800 shares $16.53 million +4.8%3.7%4.1 $22.56 8/15/2024699,300 shares $16.44 million +0.8%3.6%3.9 $23.51 7/31/2024693,500 shares $16.60 million -11.5%3.5%3.8 $23.93 7/15/2024784,000 shares $16.67 million +0.2%4.1%4.4 $21.26 6/30/2024782,100 shares $15.34 million -0.2%4.1%4.8 $19.62 6/15/2024783,400 shares $14.96 million +8.7%4.1%4.9 $19.09 5/31/2024720,900 shares $14.89 million +2.4%3.7%4.3 $20.65 5/15/2024704,000 shares $15.89 million +3.2%3.7%3.4 $22.57 4/30/2024682,400 shares $13.89 million +9.1%3.5%3.1 $20.35 4/15/2024625,400 shares $12.98 million +3.5%3.1%2.9 $20.75 3/31/2024604,000 shares $13.11 million -1.2%3.0%2.9 $21.70 3/15/2024611,200 shares $13.50 million +22.6%3.2%2.9 $22.09 2/29/2024498,400 shares $11.24 million -3.6%2.6%2.2 $22.56 2/15/2024517,200 shares $13.28 million +10.1%2.7%2.7 $25.68 1/31/2024469,900 shares $11.55 million -7.5%2.5%2.5 $24.59 1/15/2024508,200 shares $14.21 million -7.9%2.7%2.4 $27.97 12/31/2023551,900 shares $15.96 million -15.0%2.9%2.5 $28.91 12/15/2023649,400 shares $18.30 million +4.7%3.4%2.8 $28.18Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 11/30/2023620,400 shares $17.11 million -33.4%3.2%2.8 $27.58 11/15/2023931,700 shares $25.68 million +3.1%4.9%4 $27.56 10/31/2023903,600 shares $21.63 million +5.6%4.7%3.7 $23.94 10/15/2023855,900 shares $21.31 million +4.1%4.5%3.6 $24.90 9/30/2023821,900 shares $21.98 million +49.5%4.3%3.7 $26.74 9/15/2023549,800 shares $16.31 million -8.0%2.9%2.6 $29.67 8/31/2023597,900 shares $19.59 million +9.2%3.2%2.8 $32.76 8/15/2023547,400 shares $18.65 million -10.7%2.9%2.6 $34.07 7/31/2023613,100 shares $23.81 million -8.7%3.2%2.9 $38.83 7/15/2023671,800 shares $26.04 million +6.8%3.5%3.3 $38.76 6/30/2023629,100 shares $23.30 million -5.8%3.3%3.1 $37.03 6/15/2023667,600 shares $25.51 million -10.8%3.5%3.2 $38.21 5/31/2023748,700 shares $29.78 million -7.5%3.9%3.2 $39.77 5/15/2023809,500 shares $29.51 million +7.3%4.1%3.5 $36.46 4/30/2023754,300 shares $22.30 million +1.1%3.8%3.4 $29.57 4/15/2023745,800 shares $22.99 million -12.3%3.8%3.5 $30.83 3/31/2023850,000 shares $26.54 million -26.1%4.6%3.7 $31.22 3/15/20231,150,000 shares $36.78 million +26.6%6.2%4.8 $31.98 2/28/2023908,500 shares $29.79 million +5.9%4.9%3.8 $32.79 2/15/2023857,800 shares $29.16 million -4.4%4.6%3.7 $33.99 1/31/2023896,900 shares $30.30 million -23.3%4.8%3.3 $33.78 1/15/20231,170,000 shares $38.18 million +14.7%6.3%4.3 $32.63 12/30/20221,020,000 shares $30.38 million -14.3%5.5%3.7 $29.78 12/15/20221,190,000 shares $38.60 million +4.4%6.4%4.3 $32.44 11/30/20221,140,000 shares $41.35 million -1.7%6.0%4.1 $36.27 11/15/20221,160,000 shares $42.94 million -4.9%6.1%4 $37.02 10/31/20221,220,000 shares $48.35 million -4.7%5.9%4 $39.63 10/15/20221,280,000 shares $46.58 million -2.3%6.2%4.2 $36.39 9/30/20221,310,000 shares $49.94 million -3.0%6.3%4.2 $38.12 9/15/20221,350,000 shares $55.61 million -2.9%6.5%4.3 $41.19 8/31/20221,390,000 shares $60.42 million No Change6.7%4.4 $43.47 8/15/20221,390,000 shares $74.03 million -8.0%6.7%4.3 $53.26 7/31/20221,510,000 shares $90.22 million +0.7%7.3%4.4 $59.75 7/15/20221,500,000 shares $87.59 million +3.5%7.2%4.4 $58.39 6/30/20221,450,000 shares $79.07 million -5.2%7.0%4.1 $54.53 6/15/20221,530,000 shares $76.21 million -10.5%7.4%4.2 $49.81 5/31/20221,710,000 shares $93.21 million -0.6%8.2%4.5 $54.51 5/15/20221,720,000 shares $93.65 million +1.8%8.3%4.2 $54.45 4/30/20221,690,000 shares $92.75 million -3.4%8.0%4.2 $54.88 4/15/20221,750,000 shares $98.23 million +15.1%8.3%4 $56.13 3/31/20221,520,000 shares $94.86 million +0.7%N/A3.4 $62.41 3/15/20221,510,000 shares $84.94 million -7.4%7.2%3 $56.25 2/28/20221,630,000 shares $101.55 million -3.6%7.8%3.1 $62.30 2/15/20221,690,000 shares $112.37 million -15.1%8.2%3.2 $66.49 1/31/20221,990,000 shares $127.10 million -7.9%9.6%3.7 $63.87 1/15/20222,160,000 shares $172.71 million +17.4%N/A4.2 $79.96 12/31/20211,840,000 shares $185.09 million -11.5%8.9%3.8 $100.59 12/15/20212,080,000 shares $186.83 million -17.5%10.6%4.4 $89.82 11/30/20212,520,000 shares $235.67 million -4.9%12.9%5.5 $93.52 11/15/20212,650,000 shares $247.62 million -4.3%13.6%5.9 $93.44Elon Musk’s New Technology (Ad)Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.Get the full details on the AI company behind Musk’s next big move. 10/29/20212,770,000 shares $229.69 million -6.7%14.4%5.8 $82.92 10/15/20212,970,000 shares $231.72 million No Change15.4%5.4 $78.02 9/30/20212,970,000 shares $267.15 million -10.3%15.4%4.9 $89.95 9/15/20213,310,000 shares $287.18 million -4.1%17.2%4.9 $86.76 8/31/20213,450,000 shares $314.78 million -10.4%18.1%4.9 $91.24 8/13/20213,850,000 shares $362.71 million -14.3%20.2%5.1 $94.21 7/30/20214,490,000 shares $414.20 million -14.3%24.0%5.7 $92.25 7/15/20215,240,000 shares $401.54 million -6.4%28.0%6.2 $76.63 6/30/20215,600,000 shares $516.49 million -2.4%29.9%6.5 $92.23 6/15/20215,740,000 shares $415.12 million +1.2%30.7%6 $72.32 5/28/20215,670,000 shares $419.98 million -3.4%30.3%5.1 $74.07 5/14/20215,870,000 shares $395.93 million -2.7%N/A4.1 $67.45 4/30/20216,030,000 shares $479.93 million -1.3%N/A3.7 $79.59 4/15/20216,110,000 shares $543.48 million +5.9%N/A3.4 $88.95 3/31/20215,770,000 shares $532.80 million +26.0%34.6%2.9 $92.34 3/15/20214,580,000 shares $437.85 million +15.7%27.5%2.1 $95.60 2/26/20213,960,000 shares $406.89 million +37.0%28.5%1.8 $102.75 2/12/20212,890,000 shares $494.13 million -30.9%20.8%1.4 $170.98 1/29/20214,180,000 shares $386.61 million +1.0%30.1%2 $92.49 1/15/20214,140,000 shares $285.95 million +5.6%29.8%2.3 $69.07 12/31/20203,920,000 shares $198.86 million +22.1%28.2%2.4 $50.73 12/15/20203,210,000 shares $143.71 million -12.3%23.1%2.5 $44.77 11/30/20203,660,000 shares $148.71 million +20.8%27.3%3 $40.63 11/15/20203,030,000 shares $129.68 million +45.0%23.7%2.6 $42.80 10/30/20202,090,000 shares $71.46 million +16.8%16.5%2.1 $34.19 10/15/20201,790,000 shares $68.32 million -6.8%15.5%1.8 $38.17 9/30/20201,920,000 shares $76.88 million +23.9%16.6%2 $40.04 9/15/20201,550,000 shares $46.95 million +31.4%13.5%1.7 $30.29 8/31/20201,180,000 shares $34.88 million +27.3%10.6%1.5 $29.56 FLGT Short Interest - Frequently Asked Questions What is Fulgent Genetics' current short interest? Short interest is the volume of Fulgent Genetics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 2,090,000 shares of FLGT short. 10.60% of Fulgent Genetics' shares are currently sold short. Learn More on Fulgent Genetics' current short interest. What is a good short interest ratio for Fulgent Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FLGT shares currently have a short interest ratio of 7.0. Learn More on Fulgent Genetics's short interest ratio. Which institutional investors are shorting Fulgent Genetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fulgent Genetics: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fulgent Genetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.60% of Fulgent Genetics' floating shares are currently sold short. Is Fulgent Genetics' short interest increasing or decreasing? Fulgent Genetics saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,090,000 shares, an increase of 12.4% from the previous total of 1,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fulgent Genetics' float size? Fulgent Genetics currently has issued a total of 30,610,000 shares. Some of Fulgent Genetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fulgent Genetics currently has a public float of 19,720,000 shares. How does Fulgent Genetics' short interest compare to its competitors? 10.60% of Fulgent Genetics' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Fulgent Genetics: Veracyte, Inc. (7.69%), Addus HomeCare Corporation (3.73%), LifeStance Health Group, Inc. (5.12%), Celcuity, Inc. (9.43%), Progyny, Inc. (9.89%), PACS Group, Inc. (6.32%), Viridian Therapeutics, Inc. (14.53%), Aveanna Healthcare Holdings Inc. (4.86%), Teladoc Health, Inc. (13.67%), AdaptHealth Corp. (11.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Fulgent Genetics stock? Short selling FLGT is an investing strategy that aims to generate trading profit from Fulgent Genetics as its price is falling. FLGT shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fulgent Genetics? A short squeeze for Fulgent Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FLGT, which in turn drives the price of the stock up even further. How often is Fulgent Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FLGT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Veracyte Short Squeeze Addus HomeCare Short Squeeze LifeStance Health Group Short Squeeze Celcuity Short Squeeze Progyny Short Squeeze PACS Group Short Squeeze Viridian Therapeutics Short Squeeze Aveanna Healthcare Short Squeeze Teladoc Health Short Squeeze AdaptHealth Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FLGT) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access